These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 24400786

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis.
    Kria L, Ohira A, Amemiya T.
    Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):702-8. PubMed ID: 9782432
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats.
    Chen JF, Ni HF, Pan MM, Liu H, Xu M, Zhang MH, Liu BC.
    Am J Physiol Renal Physiol; 2013 Mar 15; 304(6):F676-85. PubMed ID: 23152296
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Inhibitory effect of PPARγ agonist on the proliferation of human pterygium fibroblasts.
    Zou Y, Zhang M.
    J Huazhong Univ Sci Technolog Med Sci; 2010 Dec 15; 30(6):809-14. PubMed ID: 21181377
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Antifibrotic effects of pirfenidone in rat proximal tubular epithelial cells.
    Takakura K, Tahara A, Sanagi M, Itoh H, Tomura Y.
    Ren Fail; 2012 Dec 15; 34(10):1309-16. PubMed ID: 23002925
    [Abstract] [Full Text] [Related]

  • 51. Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo.
    Li C, Rezov V, Joensuu E, Vartiainen V, Rönty M, Yin M, Myllärniemi M, Koli K.
    Sci Rep; 2018 Jul 03; 8(1):10070. PubMed ID: 29968778
    [Abstract] [Full Text] [Related]

  • 52. Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts.
    Kaneko M, Inoue H, Nakazawa R, Azuma N, Suzuki M, Yamauchi S, Margolin SB, Tsubota K, Saito I.
    Clin Exp Immunol; 1998 Jul 03; 113(1):72-6. PubMed ID: 9697986
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The inhibitive effects of proteasome inhibitor MG-132 on pterygium fibroblasts in vitro and the potential key regulators involved.
    Zhao D, Zhao H, He Y, Yang Y, Du Y, Zhang M.
    Life Sci; 2021 Apr 01; 270():119088. PubMed ID: 33482188
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis.
    Navarro-Partida J, Martinez-Rizo AB, Gonzalez-Cuevas J, Arrevillaga-Boni G, Ortiz-Navarrete V, Armendariz-Borunda J.
    Eur J Pharmacol; 2012 Mar 05; 678(1-3):71-7. PubMed ID: 22222821
    [Abstract] [Full Text] [Related]

  • 60. Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents.
    Ma Z, Pan Y, Huang W, Yang Y, Wang Z, Li Q, Zhao Y, Zhang X, Shen Z.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):220-3. PubMed ID: 24332090
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.